PRESENTATION An ISO 9001-2015 Certified Company DSIR Recognized - - PowerPoint PPT Presentation

presentation
SMART_READER_LITE
LIVE PREVIEW

PRESENTATION An ISO 9001-2015 Certified Company DSIR Recognized - - PowerPoint PPT Presentation

CORPORATE PRESENTATION An ISO 9001-2015 Certified Company DSIR Recognized R&D Facility D&B D-U-N-S Number 65-061-8049 Symphony Pharma Life Sciences July 2019 Page 2 ABOUT US Established in 2008 Technology driven organization


slide-1
SLIDE 1

CORPORATE PRESENTATION

An ISO 9001-2015 Certified Company DSIR Recognized R&D Facility D&B D-U-N-S Number 65-061-8049

July 2019 Symphony Pharma Life Sciences

slide-2
SLIDE 2

ABOUT US

 Established in 2008  Technology driven organization founded by scientists with proven industrial track record  Expertise in Pharmaceutical and Chemical Research & Development  Research partner for Global Innovator, Generic, Biotech, Biopharma and Chemical companies VISION & MISSION “TO ENHANCE VALUE BY PARTNERING WITH THE GLOBAL PHARMACEUTICAL AND CHEMICAL INDUSTRIES ACROSS ITS VALUE CHAIN” Page 2

Symphony Pharma Life Sciences

slide-3
SLIDE 3

LEADERSHIP TEAM-KEY MANAGEMENT

  • Dr. Raju

ju Sir iris isil illa la – COO  25+ years of Pharmaceutical Industry experience working with Dr. Reddys for 15 years and Symphony for 10 Years.  Expertise in Med. Chem, Process Research & Development, and regulatory filings (NDA & DMFs).  Co-inventor for several US patents and international publications.

  • Dr. Ramaj

ajeyam am Selv lvaraj aj – Prin incip ipal al Scien ientis ist/H /Head ad Chemic ical al Research  15+ Years of experience in Synthetic Organic Chemistry, discovery Research and NCE development.  Experienced at AstraZeneca, Aurigene (DRL) and studied at IIT Madras, Univ. of Delaware (USA), Purdue Univ. (USA) Dr Dr. . Sreedhar ar– Prin incipal ipal Scien ientis ist/H /Head ad Analy lyti tical al Research  10+ years of experience in Analytical research and method development etc.

  • Mr. May

ayukh kh Mukherje jee– Senio ior Manage ager, Busin iness ss Deve velo lopment nt  15+ years of experience in International business development, strategy, operations, sales and marketing  Experienced at TCG Lifesciences (Formerly Chembiotek)

  • Mr. Narsimlu

imlu– Senio ior Manage ger, Supply ly chain in manage agement nt  15+ experience in Supply chain management, procurements and imports/export documentation.

Page 3

Symphony Pharma Life Sciences

slide-4
SLIDE 4

TEAM

Page 4

Symphony Pharma Life Sciences

 More than 90% are technically qualified  Team members with Qualification of Ph.D, M.Sc and Engineering  Scientific collective experience of over 100 years  Extensive Synthetic chemistry, Analytical & Manufacturing skills  Expertise milligrams to commercial scale  Scientific advisory board, members from well-known institutes (US & India)

slide-5
SLIDE 5

BUSINESS FOCUS

Contract Research (Full-Time Equivalent - FTE) Custom Synthesis (Fee For Services-FFS) Product Development (Process & Analytical) .

Page 5

Symphony Pharma Life Sciences

slide-6
SLIDE 6

Contract Research (FTE services)

Page 6

Symphony Pharma Life Sciences

 Efficient/ Experienced Manpower  Deliverables up to 1000g

  • this higher quantity or repeated quantity is also a part of FTE work with

exclusive of key raw materials cost.

 Competitive pricing based on chemistry  Integrated project management

  • support all documentation (record book and bi-weekly tech.reports)
slide-7
SLIDE 7

Custom Synthesis (Fee For Services)

Page 7

Symphony Pharma Life Sciences

 Short turn around time for enquiry response

  • 3-5 days for quote submission.

 Lab to commercial scale

  • few milligrams to multi kilogram

scale  Adherence to strict timelines & Specifications  Product characterization

  • COA and individual data will be

provided with impurity profile etc..

slide-8
SLIDE 8

PRODUCT DEVELOPMENT

Page 8

Symphony Pharma Life Sciences

 Rigorous Literature Search  Regulatory implication study  Cost effective and environment friendly process  Robust scalable process  IP generation for patent filings  Complete tech-pack preparation  Access to exclusive market opportunities  CMC documentation support

slide-9
SLIDE 9

INFRASTRUCTURE

Page 9

Symphony Pharma Life Sciences

 25,000+ sq. ft research facility on a 2+ acre lot located in Research & Knowledge park (Biotech park) in Hyderabad  Working space for 50 Scientists-scope for expansion of another 50 scientists  Fit-for-purpose labs with 18 fume hoods-scope for expansion of another 18 fume hoods  Pilot plant with 100Lt to 500 Lt GLR and SSR reactors for scale-up of 100 Kg quantities  Analytical Lab with well equipped separation sciences instruments like HPLC, GC etc..  Quality assurance division to support documentation

slide-10
SLIDE 10

Early y phase drug Discov

  • very

ry/Med. ed.chem em Custom Synthesis s (pharma& a& chemical)

  • Synthesis of building blocks (100+), scaffolds (35+) &

analogues/libraries (200+) of NCE’s

  • Developmental work for NCE compounds.
  • Synthesis & supply of non-catalogue compounds at all scales
  • Advanced Intermediates & key starting materials
  • Fine & Specialty chemicals
  • Working standards , Impurities & Metabolites

Process ss R&D

  • Exploring all the synthetic routes/ selection
  • Process Development, Optimization & Validations
  • Non-infringing route development

Analytical al R&D

  • Analytical method development, Validations & Transfer
  • Stability Study : Accelerated & Long term
  • Impurity profiling

cGMP pilot plant (up to 100 Kg)

  • Supply of pre-clinical and clinical drug substance including CMC

documentation

  • Supply of API Advanced intermediates & Fine & Specialty chemicals

CHEMISTRY SERVICES

Page 10

Symphony Pharma Life Sciences

slide-11
SLIDE 11

R&D (PROCESS & CHEMICAL) STRENGTHS

 Route Scouting  Quick process development to provide proof of concept  Optimization for a robust and scalable process  In-process controls  Process validation and scale up studies  Preparation of standards samples & impurities  Technology transfer to manufacturing sites  Stability testing and Degradation studies  Solid state studies  Multi-step chiral synthesis  Chiral resolution  Carbohydrate chemistry  Amino acid chemistry  Peptide synthesis (solution phase)  Bio-transformations  Suzuki Coupling, Heck Coupling and Sonogashira Coupling  Grignard reaction  Borane / Diborane chemistry  Carbonylation  Swern Oxidation

Page 11

Symphony Pharma Life Sciences

slide-12
SLIDE 12

RFP

Literature, ROS Selection, Costing

RFP

RFP Received Proposal, Timelines, Deliverables

RFP

Contract Signing & Project Initiation

RFP

Feasibility Scale-up Scale-up Feasibility study Technology Transfer Manufacturing Feasibility Lab Validation Scale-up Analytical method development Commercial manufacturing Manufacturing Feasibility Process Optimization Scale-up Lab Sample preparation Target Delivery Manufacturing

Our Approach for Process development & Scale-up

Symphony Pharma Life Sciences

Page 12

slide-13
SLIDE 13

ANALYTICAL R&D STRENGTHS

Symphony Pharma Life Sciences

 Method development  Specification development  Impurity profiling  Stability testing and Degradation studies  Release of products with COA  Qualification of working standards/Reference standards  Spectral characterization by NMR, IR, LCMS  Solid state characterization by XRD, DSC, IR  Support to regulatory filings Page 13

slide-14
SLIDE 14

SCALE-UP : DOCUMENTATION SUPPORT

Non-GMP: P:  Campaign report  COAs of KSMs, Intermediates & Final  ROS & Brief manufacturing details GMP:  Approved certificate from local FDA  Campaign report  BMRs  Operational SOPs  COAs of KSMs, Intermediates & Final  Specs & MOAs KSMs, Intermediates & Final  Technology transfer report from R&D to plant  Material Vendor qualification documents Symphony Pharma Life Sciences

Page 14

slide-15
SLIDE 15

GMP PILOT PLANT INFRASTRUCTURE

 500 Lt- SSR  250 Lt-SSR  100 Lt-SSR  250 Lt- GLR  100 LT-GLR  Vacuum tray drier  (25-50 Kg drying in single slot)  Blender  Miller  Oil freed boiler  Chiller upto-10 0C Page 15

Symphony Pharma Life Sciences

slide-16
SLIDE 16

PRODUCTS: BUILDING BLOCKS

Bicyclo compounds Azaindoles Thiophenes Quinoxalines Pyrazoles Imidazoles Pyridines Pyrimidines Furans Benzaxozoles Benziimidazol es Symphony Pharma Life Sciences

Page 16

slide-17
SLIDE 17

PRODUCTS: APIs & INTERMEDIATEs

Lacosamide (US DMF Ref 26594) Bazedoxifene acetate Mirabigron Cinacalcet hydrochloride Dabigatran Etexilate Dronerdarone hydrochloride Flupiritine maleate Vemurafenib Plerixafor Eliglustat Brivaracetam Symphony Pharma Life Sciences

Page 17

slide-18
SLIDE 18

PRODUCTS: API-IMPURITIES (Quantity: 50mg to 1000gm)

 Bazedoxifene  Mirabigron  Dronedarone Hydrochloride  CinacalcetHydrochloride  Lacosamide  Dabigatran Etexilate Mesylate  Asenapine  Desloratadine  Valsartan  Atorvastatin  Bazedoxifene  Irbesartan  Olmesartan  Ranolazine  Lurasidone  Lansoprazole  Fluconazole  Ramipril  Eslicarbazepine  Carvedilol  Rosuvastatin  Eszopiclone  Valganciclovir  Oxaprozin  Amlodipine  Linezolid  Escitalopram Oxalate  Famotidine  Solifenacin  Vilazodone  Lamotrigine  Sitagliptin  Ezetimibe  Linagliptin  Voriconazole  Saxagliptin  Agomelatine  Tolterodine  Zafirlukast  Pemetrexed  Lenalidomide  Nateglinide  Pregabalin  Enalapril  Bicalutamide  Montelukast

Symphony Pharma Life Sciences

Page 18

slide-19
SLIDE 19

 Invented about 150 new pigments under FTE research program for US chemical major and some of these new pigments moving toward commercial launching globally.  In-house development of >25 NCEs and supplied as clinical substances to discovery Pharmas  Developed 6 APIs with 1 USDMF  Started with synthesis at 250 mg scale and end delivery up to 250 Kg scale to single Pharma  >250 in-house stock of impurities  Experience in working with >150 building blocks  Successfully executed several projects in record time from process development to multi-kilo scale for innovator and generic pharma companies across the globe  Customized services to provide cost-effective and robust processes for API and NCE development  Scientific advisory board members from well known institutes of US and India  Strategic research partner for some of the top Indian pharma companies

Track Record

Page 19

Symphony Pharma Life Sciences

slide-20
SLIDE 20

Page 20

Th Than ank k You

  • u

USA USA

Symph mphon

  • ny Phar

arma a Lif ife Scien iences s Inc nc.

103 Morgan Lane, Suite#104 Plainsboro, NJ – 08536, USA Phone: ne: +1 609.269.2700

INDIA IA

Symph phon

  • ny Phar

arma ma Lif ife Scien iences s Inc. nc.

7/A, Biotech Park, Phase - II Genome Valley, Shamirpet, Hyderabad - 500 078, Telangana, India Phone: ne: +91 9830554746

Symphony Pharma Life Sciences